Leinco Technologies

For scientists in life sciences discovery, and biopharmaceutical and diagnostics segments utilizing antibodies, biologically active proteins, and assays, reproducible science is the key to unlocking the scientific doors. Leinco Technologies Inc. adheres to ISO 9001:2015 and ISO 13485:2016 quality standards, and provides access to antibodies and proteins used in a broad range of life sciences applications uncovering interactions in cancer, infectious diseases and immunology. Our proprietary techniques result in the highest purity antibodies (monoclonal, recombinant and polyclonal) and proteins enabling scientists globally to generate reproducible science and faster time to scientific results across a broad range of cell, tissue and in vivo applications (e.g. spatial biology, flow cytometry, pre-clinical in vivo and in vitro studies). For our many partners, the Leinco scientists with over 30 years’ experience take a consultative approach and are committed to delivering the highest quality CDMO services (e.g. antibody scale-up and purification, optimized conjugation to reporter molecules and assay development/manufacturing) that save time and ensure our customers are successful in their programs.